208 related articles for article (PubMed ID: 23269996)
41. The Effects of Introducing Mixed Payment Systems for Physicians: Experimental Evidence.
Brosig-Koch J; Hennig-Schmidt H; Kairies-Schwarz N; Wiesen D
Health Econ; 2017 Feb; 26(2):243-262. PubMed ID: 26708170
[TBL] [Abstract][Full Text] [Related]
42. Medicare fees and physicians' medicare service volume: beneficiaries treated and services per beneficiary.
Hadley J; Reschovsky JD
Int J Health Care Finance Econ; 2006 Jun; 6(2):131-50. PubMed ID: 16783506
[TBL] [Abstract][Full Text] [Related]
43. Decline in physician referrals to health department clinics for immunizations: the role of vaccine financing.
Szilagyi PG; Humiston SG; Pollard Shone L; Kolasa MS; Rodewald LE
Am J Prev Med; 2000 May; 18(4):318-24. PubMed ID: 10788735
[TBL] [Abstract][Full Text] [Related]
44. Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.
Parikh AR; Keating NL; Liu PH; Gray SW; Klabunde CN; Kahn KL; Haggstrom DA; Syngal S; Kim B
J Oncol Pract; 2016 Mar; 12(3):e308-19, 259-60. PubMed ID: 26962170
[TBL] [Abstract][Full Text] [Related]
45. Physicians' financial incentives in five dimensions: a conceptual framework for HMO managers.
Magnus SA
Health Care Manage Rev; 1999; 24(1):57-72. PubMed ID: 10047979
[TBL] [Abstract][Full Text] [Related]
46. Is There Variation in Procedural Utilization for Lumbar Spine Disorders Between a Fee-for-Service and Salaried Healthcare System?
Schoenfeld AJ; Makanji H; Jiang W; Koehlmoos T; Bono CM; Haider AH
Clin Orthop Relat Res; 2017 Dec; 475(12):2838-2844. PubMed ID: 28074438
[TBL] [Abstract][Full Text] [Related]
47. Effect of payment incentives on cancer screening in Ontario primary care.
Kiran T; Wilton AS; Moineddin R; Paszat L; Glazier RH
Ann Fam Med; 2014 Jul; 12(4):317-23. PubMed ID: 25024239
[TBL] [Abstract][Full Text] [Related]
48. [Health services research in oncology using claims data].
Hoffmann F; Glaeske G
Med Klin (Munich); 2010 Jun; 105(6):409-15. PubMed ID: 20582501
[TBL] [Abstract][Full Text] [Related]
49. The effect of financial incentives on physicians' behaviour in health maintenance organizations.
McCleary K; Asubonteng P; Munchus G
J Manag Med; 1995; 9(1):8-26. PubMed ID: 10142782
[TBL] [Abstract][Full Text] [Related]
50. Virtual Management of Patients With Cancer During the COVID-19 Pandemic: Web-Based Questionnaire Study.
Tashkandi E; Zeeneldin A; AlAbdulwahab A; Elemam O; Elsamany S; Jastaniah W; Abdullah S; Alfayez M; Jazieh AR; Al-Shamsi HO
J Med Internet Res; 2020 Jun; 22(6):e19691. PubMed ID: 32501807
[TBL] [Abstract][Full Text] [Related]
51. Supply sensitive services in Swiss ambulatory care: an analysis of basic health insurance records for 2003-2007.
Busato A; Matter P; Künzi B; Goodman DC
BMC Health Serv Res; 2010 Nov; 10():315. PubMed ID: 21092250
[TBL] [Abstract][Full Text] [Related]
52. Doctors' views of patient expectations of medical care in Zhejiang Province, China.
Wu D; Lam TP; Lam KF; Zhou XD; Sun KS
Int J Qual Health Care; 2017 Oct; 29(6):867-873. PubMed ID: 29025020
[TBL] [Abstract][Full Text] [Related]
53. Influence of financial productivity incentives on the use of preventive care.
Wee CC; Phillips RS; Burstin HR; Cook EF; Puopolo AL; Brennan TA; Haas JS
Am J Med; 2001 Feb; 110(3):181-7. PubMed ID: 11182103
[TBL] [Abstract][Full Text] [Related]
54. Analysis of Physician Variation in Provision of Low-Value Services.
Schwartz AL; Jena AB; Zaslavsky AM; McWilliams JM
JAMA Intern Med; 2019 Jan; 179(1):16-25. PubMed ID: 30508010
[TBL] [Abstract][Full Text] [Related]
55. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
Hurria A; Wong FL; Pal S; Chung CT; Bhatia S; Mortimer J; Somlo G; Hurvitz S; Villaluna D; Naeim A
Oncologist; 2009 Sep; 14(9):883-90. PubMed ID: 19726455
[TBL] [Abstract][Full Text] [Related]
56. Financial incentives for physicians in HMOs. Is there a conflict of interest?
Hillman AL
N Engl J Med; 1987 Dec; 317(27):1743-8. PubMed ID: 3696187
[TBL] [Abstract][Full Text] [Related]
57. The effects of payment method on clinical decision-making: physician responses to clinical scenarios.
Shen J; Andersen R; Brook R; Kominski G; Albert PS; Wenger N
Med Care; 2004 Mar; 42(3):297-302. PubMed ID: 15076830
[TBL] [Abstract][Full Text] [Related]
58. Compliance with quality prescribing indicators linked to financial incentives: what about not incentivized indicators?: an observational study.
Fernández Urrusuno R; Pérez Pérez P; Montero Balosa MC; Márquez Calzada C; Pascual de la Pisa B
Eur J Clin Pharmacol; 2014 Mar; 70(3):303-11. PubMed ID: 24297343
[TBL] [Abstract][Full Text] [Related]
59. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
[TBL] [Abstract][Full Text] [Related]
60. Oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional study.
Salgado TM; Radwan RM; Hickey Zacholski E; Mackler E; Buffington TM; Musselman KT; Irvin WJ; Perkins JM; Le TN; Dixon DL; Farris KB; Sheppard VB; Jones RM
Support Care Cancer; 2023 Jul; 31(8):450. PubMed ID: 37421495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
